Probiotics During Anorexia Nervosa Refeeding
Continue the probiotics during initial refeeding, as emerging evidence suggests they may enhance weight restoration and improve gastrointestinal symptoms without interfering with nutritional rehabilitation.
Primary Rationale
The cornerstone of anorexia nervosa treatment remains aggressive nutritional rehabilitation with individualized weight-gain targets (0.5–1 kg/week for outpatients, 1–1.5 kg/week for inpatients), and nothing should interfere with this priority 1. However, probiotics appear to complement rather than hinder this process.
Supporting Evidence for Continuation
The strongest clinical trial data demonstrates probiotics may accelerate recovery:
A randomized controlled trial in pediatric AN patients showed that Lactobacillus reuteri DSM 17938 supplementation resulted in significantly higher rates of body weight normalization (93% vs 63%, p=0.04) and increased stool frequency (6.4 vs 4.2 stools/week) at 6 months compared to placebo 2.
The same study found trends toward improved bone mineral density recovery (8/15 patients vs 3/16 in placebo group), though this did not reach statistical significance 2.
Probiotics address common refeeding complications:
Constipation is frequent and difficult to manage during refeeding, and can compromise nutritional rehabilitation by causing discomfort that reinforces food avoidance 2.
Probiotic supplementation may serve as a simple and safe adjuvant therapy specifically for constipation management during the refeeding phase 2.
Mechanistic Considerations
Gut microbiome alterations in AN are clinically relevant:
Severe starvation induces microbiome changes that do not normalize with weight gain alone 3.
Patients with AN show reduced abundance of short-chain fatty acid-producing species (Firmicutes, including Roseburia, Agathobacter, and Faecalibacterium) 4.
Greater gut microbiome diversity correlates with better implicit learning capacity (r=0.45, p=0.013), suggesting cognitive benefits beyond gastrointestinal effects 4.
Evidence Limitations and Caveats
The research base remains preliminary:
A 2024 systematic review identified only 3 randomized controlled trials, all in children and adolescents, with mixed results on short-term weight gain and immunological parameters 5.
No high-quality evidence exists specifically addressing whether to continue versus discontinue home probiotics during hospitalization 5.
Research gaps exist regarding psychological and eating disorder symptomatology outcomes 5.
Practical Implementation
If continuing probiotics:
Document the specific strain and dosage the patient has been taking at home.
Monitor for any gastrointestinal side effects, though probiotics are generally well-tolerated 2.
Do not allow probiotic administration to delay or reduce caloric intake—nutritional rehabilitation remains the primary intervention 1.
Consider multi-strain formulations or Lactobacillus reuteri DSM 17938 if selecting a new probiotic, as these have the most supporting data 2.
Common pitfall to avoid:
- Do not position probiotics as a primary treatment or allow them to distract from the multidisciplinary approach (medical, psychiatric, psychological, and nutritional specialists) required for comprehensive AN management 1.